At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
Valveless recirculating insufflation (VTI) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System: A Randomized Control Trial
In Brief
A clinical study evaluating Valveless recirculating insufflation (VTI) and Conventional pressure for Pain. Completed, enrolled 41 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if the Airseal System will reduce post-operative pain and reduce the need for narcotics in laparoscopic living kidney donor surgeries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
CollaboratorsSurgiQuest, Inc.
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartAug 2014
First PostedOct 2014
Primary CompletionDec 2015
Study CompletionFeb 2016
TodayJul 2026
First PostedOct 10, 2014
Enrollment StartAug 1, 2014
Primary CompletionDec 1, 2015
Study CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.7 years ago
Interventions
Valveless recirculating insufflation (VTI)device
10 mmHg target pressure
Conventional pressuredevice
15 mmHg target pressure